Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_assertion type Assertion NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_head.
- NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_assertion description "[CSS has 2 major clinical subsets, antineutrophil cytoplasmic antibody (ANCA)-positive, with features of small-vessel vasculitis, and ANCA-negative, in which organ damage is mainly mediated by tissue eosinophilic infiltration; analysis of HLA-DRB4 in patients categorized by different numbers of vasculitic manifestations (purpura, alveolar hemorrhage, mononeuritis multiplex, rapidly progressive glomerulonephritis, and constitutional symptoms) showed that its frequency strongly correlated with the number of vasculitis symptoms (P for trend = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_provenance.
- NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_assertion evidence source_evidence_literature NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_provenance.
- NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_assertion SIO_000772 17763415 NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_provenance.
- NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_assertion wasDerivedFrom befree-20140225 NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_provenance.
- NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_assertion wasGeneratedBy ECO_0000203 NP301964.RAKvV2TRfWcaT8DYLGx4kpACScyoGoLhcDAVbSftuDLzE130_provenance.